Xuedong Wei
Papers
1
Total Citations
2
H-Index
1
About
No biography available yet.
Research Focus
Key Achievements
1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Neoadjuvant darolutamide plus androgen deprivation therapy for high-risk/very high-risk localized prostate cancer: A multicenter, open-labeled, single-arm phase II trial.
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Soochow University
Top Papers
- 1
Key Collaborators
Not generated yet